Steven Gerrard could reject a sensational return to the Rangers, says former Liverpool teammate Didi Hamann. Gerrard is on the list of high-profile contenders linked with the managerial hotseat at ...

Two-and-a-half years on from his sacking at Aston Villa, Steven Gerrard is being tipped to make a return to English football. The former Liverpool captain has been out of work since the end of ...

Honestly I probably watched pornography first when I was maybe 11,' Lily admitted. 'I've always known about it, I always knew it was a thing. I always thought it was very normal to watch.

Today's announcement could potentially add to a string of bad tariff news that has cost Roche 10.9%, Lilly 14%, and AstraZeneca stock 14.4% over the past week. Still, it remains to be seen ...

The results could be harmful to them in more ways than one. Despite this issue, Eli Lilly remains a top stock to buy. As everyone who follows equity markets knows, stocks are feeling the heat from ...

One of them is the pharmaceutical industry. However, some major executives in the sector are not optimistic, including Eli Lilly's (NYSE: LLY) CEO, David Ricks. Let's see what he had to say about ...

In this article, we are going to take a look at where Eli Lilly & Company (NYSE:LLY) stands against other defensive stocks Billionaire Ken Fisher is betting on. Ken Fisher, an American billionaire ...

Ex-Manchester United defender Rio Ferdinand sparked a fierce debate on his podcast by placing Steven Gerrard above Kevin De Bruyne in a list of the Premier League's best midfielders. The topic has ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim Cramer discusses. On Thursday, April 3 rd, the host of Mad Money opened ...

Eli Lilly, which had seen a three-day decline, was upgraded to Buy by analyst Asad Haider. He said the company's strong position in the obesity drug market offers a compelling entry point.

Following a three-day selloff amid market turmoil attributed to the Trump administration’s sweeping tariffs announced last week, Eli Lilly (NYSE:LLY) shares traded higher in the premarket on ...

April 8 - Eli Lilly (NYSE:LLY) shares rose about 5% Tuesday morning after Goldman Sachs (NYSE:GS) upgraded the pharmaceutical giant to Buy from Neutral, citing confidence in its leadership in the ...